1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. VEGFR
  4. VEGFR Ligand

VEGFR Ligand

VEGFR Ligand (1):

Cat. No. Product Name Effect Purity
  • HY-P991141
    Inlecitug
    Ligand
    Inlecitug is a chimeric monoclonal antibody targeting human VEGFR2/KDR/Flk-1 (kinase insert domain receptor). Inlecitug specifically binds to VEGFR2/KDR/Flk-1, blocking the binding of vascular endothelial growth factor (VEGF) to VEGFR2/KDR/Flk-1 and inhibiting angiogenesis, thus exerting antitumor activity. Inlecitug is promising for research of cancers.